The Role of AI and LLMs in Accelerating Precision Medicine
Read more
Velsera in a nutshell
Accelerate your research breakgthroughs and novel drug launches.
Accelerate the scale up of your genetic testing & unlock the value in your data.
Bring new tests to market and scale up testing fast.
Accelerate your research breakthroughs and unlock the value in your data.
Active clinical NGS lab customers
NGS samples sequences
Productized NGS assays available 'off the shelf'
Year over year sequencing volume
Top pharmas supported by our technology-enabled products and services
Researchers using the Seven Bridges Platform
Patients
Of multi-omic molecular data
Velsera solves problems by combining deep expertise with cutting edge tech
Our Trusted Research Environment (TRE) for bioinformatic analysis & pipeline development.
Our award winning reference genome tool.
Our data harmonization and secure sharing platform.
Our tertiary analytics & reporting tool for clinical NGS diagnostics.
Our best in class, IVD-grade variant interpretation knowledge base.
Supporting health & life science companies to combine and harmonize their data.
Supporting researchers and diagnostic developers to build better workflows
Supporting researchers to run efficient and effective studies.
Supporting clinical diagnostic labs and diagnostic test developers to navigate the changing regulatory environment.
Supporting diagnostic labs to start and scale-up their NGS testing.
Harmonize and augment your data to unlock the value within.
Use cutting edge technology to make new discoveries and breakthroughs faster.
Develop better diagnostics that scale faster, accelerating novel drug uptake.
Bring new tests to market and scale-up fast.
Effectively navigate and grow in the changing regulatory environment.
Accelerate the scale up of your genetic testing & unlock the value in your data.
Hear how leading life sciences companies and clinical diagnostic labs trust our technology to accelerate discovery and improve patient care.
Blog
On April 2, 2025 | By Zelia Worman
Read more
Blog
On April 14, 2025 | By Laura Buttrum
Read more
Blog
On December 3, 2024 | By Julie Furt
Read more
News
On February 20, 2025 | By Brian Lassiter
Read more